Bradley Messmer

Dr. Messmer received his PhD in molecular biology from the Rockefeller University in 2000 and did postdoctoral training at the Feinstein Institute for Medical Research in Manhasset, New York. He went on to join the faculty there before moving to the Moores UCSD Cancer Center in 2004, where he maintains a lab. Dr. Messmer’s academic work has focused on the application of novel technologies to problems in cancer diagnosis, monitoring, and treatment.

In 2013, Dr. Messmer founded Abreos Biosciences with Dr. Peter Haberz of the Scripps Research Institute to commercially develop technologies he developed at UCSD. The company, located in San Diego, California, has received multiple small business grants from the National Institutes of Health (US) and is developing products for therapeutic drug monitoring and authentication as well as massively parallel multiplex protein analyses.